Publication Date:
1988-11-18
Description:
A general chemical strategy has been developed whereby antibody combining sites can be selectively derivatized with natural or synthetic molecules, such as catalytic groups, drugs, metals, or reporter molecules. Cleavable affinity labels were used to selectively introduce a thiol into the combining site of the immunoglobulin A MOPC 315. This thiol acted both as a nucleophile to accelerate ester thiolysis 60,000-fold and as a handle for selectively derivatizing the antibody with additional functional groups. For example, derivatization of the antibody with a fluorophore made possible a direct spectroscopic assay of antibody-ligand complexation. This chemistry should not only extend our ability to exploit antibody specificity in chemical catalysis, diagnostics, and therapeutics, but may also prove generally applicable to the functional modification of other proteins for which detailed structural information is unavailable.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Pollack, S J -- Nakayama, G R -- Schultz, P G -- AI24695-02/AI/NIAID NIH HHS/ -- New York, N.Y. -- Science. 1988 Nov 18;242(4881):1038-40.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Department of Chemistry, University of California, Berkeley 94720.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/3194752" target="_blank"〉PubMed〈/a〉
Keywords:
Affinity Labels
;
Animals
;
*Antigen-Antibody Reactions
;
*Binding Sites, Antibody
;
Chemical Phenomena
;
Chemistry
;
Dinitrobenzenes
;
Immunoglobulin Fab Fragments
;
Mice
;
Spectrometry, Fluorescence
;
Sulfhydryl Compounds
Print ISSN:
0036-8075
Electronic ISSN:
1095-9203
Topics:
Biology
,
Chemistry and Pharmacology
,
Computer Science
,
Medicine
,
Natural Sciences in General
,
Physics
Permalink
